194 related articles for article (PubMed ID: 3033326)
1. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
Bowman MR; Lyles DS; Parce JW
J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM; Bevan MJ; Lefrancois L
J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
[TBL] [Abstract][Full Text] [Related]
3. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
Ciavarra R; Forman J
J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
[TBL] [Abstract][Full Text] [Related]
4. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
[TBL] [Abstract][Full Text] [Related]
5. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
[TBL] [Abstract][Full Text] [Related]
6. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
Roscoe DM; Ishikawa K; Lyles DS
J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
Jennings SR
J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
[TBL] [Abstract][Full Text] [Related]
8. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
9. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
[TBL] [Abstract][Full Text] [Related]
10. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
Forman J; Goodenow RS; Hood L; Ciavarra R
J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
[TBL] [Abstract][Full Text] [Related]
11. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.
Puddington L; Bevan MJ; Rose JK; Lefrançois L
J Virol; 1986 Nov; 60(2):708-17. PubMed ID: 3022003
[TBL] [Abstract][Full Text] [Related]
12. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
[TBL] [Abstract][Full Text] [Related]
13. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
Sakita I; Hörig H; Sun R; Wang F; Nathenson SG
J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005
[TBL] [Abstract][Full Text] [Related]
14. Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells.
Kündig TM; Bachmann MF; Lefrancois L; Puddington L; Hengartner H; Zinkernagel RM
J Immunol; 1993 May; 150(10):4450-6. PubMed ID: 8097755
[TBL] [Abstract][Full Text] [Related]
15. Differential genetic requirements for in vivo and in vitro induction of T-killer and T-suppressor cells in the mutant H-2Kb system and the cross-reactivity of the T-killer clones.
Brondz BD; Kahn ES; Chervonsky AV; Isakova VR; Apasov SG; Blandova ZK
Exp Clin Immunogenet; 1987; 4(4):211-21. PubMed ID: 2978841
[TBL] [Abstract][Full Text] [Related]
16. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
17. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
[TBL] [Abstract][Full Text] [Related]
18. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
Ciavarra RP; Burgess DH
Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
[TBL] [Abstract][Full Text] [Related]
19. Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.
Ruebush MJ; Hale AH; Harris DT
Infect Immun; 1981 May; 32(2):513-7. PubMed ID: 6265359
[TBL] [Abstract][Full Text] [Related]
20. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
Byrne JA; Ahmed R; Oldstone MB
J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
